June 24, 2011 | Filed under: Health,News | Posted by:
New data show that the way Procrit, Epogen, and Aranesp are used in patients with chronic kidney disease puts them at risk of heart attacks, stroke, and death. More conservative dosing is needed.
Posted by
on June 24, 2011. Filed under Health, News.
You can follow any responses to this entry through the RSS 2.0.
You can skip to the end and leave a response. Pinging is currently not allowed.
Posted by
on June 24, 2011. Filed under